Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy of Lanreotide Autogel/Depot (LAN) vs Placebo (PBO) for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Study Wolin, E. M., Fisher, G. A., Kunz, P. L., Liyanage, N., Lowenthal, S., Mirakhur, B., Pommier, R. F., Shaheen, M., Vinik, A. NATURE PUBLISHING GROUP. 2016: S468
View details for Web of Science ID 000395764601507